+46.1%
GSK vs DVA
+89.4%
-43.3%
-28.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | DVA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.0% | -0.9% | -0.1% | -0.9% |
| 7D | -5.4% | -0.2% | -5.2% | -5.4% |
| 30D | -4.6% | +1.7% | -6.3% | -4.8% |
| 3M | -5.1% | -8.7% | +3.6% | -4.4% |
| 6M | -11.4% | +19.7% | -31.1% | -13.9% |
| YTD | +0.7% | +59.6% | -58.9% | -6.0% |
| 1Y | +23.0% | +37.1% | -14.1% | +17.0% |
| All | +46.1% | +89.4% | -43.3% | +38.8% |
Cumulative growth
Daily Returns
Daily percentage return beside DVA.
Daily Out/Under-Performance
Portfolio return minus DVA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × DVA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded DVA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling